Alcohol Blocks Liver Cholesterol Adaptation and Drives Fibrosis via KDM5B
New research shows alcohol disrupts cholesterol clearance and triggers liver fibrosis, pointing to potential therapeutic targets in patients.
Alcohol consumption impairs the liver’s natural ability to process and adapt to a high-cholesterol diet, leading to dangerous lipid accumulation, inflammation, and fibrosis. Researchers discovered that regular alcohol intake disrupts critical cholesterol clearance pathways in liver cells, revealing a key molecular mechanism behind advanced liver damage. The findings provide new clarity on how dietary components synergize with alcohol to accelerate liver disease progression in both male and female subjects.
How Does Alcohol Block the Liver From Handling Dietary Cholesterol?
To investigate how dietary factors influence alcohol-associated liver disease, Samson Mah and colleagues at the University of Kansas Medical Center fed mice a high-cholesterol diet alongside drinking water containing 20 percent ethanol for a period of 10 weeks. While mice fed only high cholesterol managed to adapt by ramping up cholesterol metabolism and secretion in liver cells, the introduction of alcohol completely stalled this protective response. The detailed findings are published in Hepatology communications.
The research team utilized advanced spatial transcriptomics to map gene expression across individual cells within the tissue architecture. They observed that alcohol significantly suppressed key genes responsible for cholesterol transport and bile acid synthesis, including Apoa1, Abcg8, Cyp7b1, and Cyp27a1. This suppression resulted in a sharp drop in serum levels of high-density lipoprotein cholesterol, serum amyloid A, and 27-hydroxycholesterol.
What Role Does the Enzyme KDM5B Play in Liver Injury?
The investigators found that an enzyme called lysine demethylase 5B, or KDM5B, plays a central part in driving this pathological response. KDM5B acts as an epigenetic regulator that represses gene transcription by removing methyl groups from histone proteins at active gene promoters. Chronic alcohol exposure upregulated KDM5B expression in hepatocytes, which directly repressed the promoter of the Abcg8 gene, a critical transporter responsible for moving cholesterol out of liver cells into bile.
When the researchers genetically knocked out Kdm5b specifically in the hepatocytes of mice, the animals were protected against alcohol-induced fibrosis and steatosis. This genetic protection worked by restoring the expression of Abcg8, which enhanced cholesterol secretion and prevented toxic lipid buildup within the liver tissue.
Are There Distinct Differences Between Male and Female Liver Responses?
The study revealed notable sex-specific differences in how the liver responds to the combination of alcohol and high cholesterol. In female mice, alcohol exposure strongly promoted the production of pro-inflammatory cytokines and increased the expression of Tgfb1, a major driver of fibrogenic signaling and tissue scarring. In contrast, male mice developed liver injury and fibrosis through alternative mechanisms that were heavily linked to impaired cholesterol efflux and disrupted cellular zonation.
Both male and female mice exposed to the combination treatment exhibited significant weight changes, elevated liver enzyme levels, and enlarged, nodular livers indicative of advanced pathology. However, the precise molecular drivers of inflammation varied between the sexes, underscoring the complexity of metabolic and alcoholic liver disease interactions.
Could Blood Markers Help Predict Patient Survival Outcomes?
The team also examined human clinical data and found that circulating levels of 27-hydroxycholesterol were severely reduced in patients with advanced liver disease, particularly among individuals with alcohol-associated liver disease and primary sclerosing cholangitis. Furthermore, lower levels of this intermediate molecule correlated strongly with higher Model for End-Stage Liver Disease scores, which measure disease severity.
Patients who maintained higher 27-hydroxycholesterol levels demonstrated significantly better transplant-free survival rates than those with low levels. While these human observations require confirmation in larger cohorts, they suggest that monitoring cholesterol metabolism intermediates could offer valuable prognostic information for managing patients with steatotic liver disease.
The research was published in Hepatology communications on November 20, 2026.
This article has been fact checked for accuracy, with information verified against reputable sources. Learn more about us and our editorial process.
Last reviewed on .
Article history
- Latest version
Reference(s)
- Mah, Samson., et al. “Alcohol impairs liver adaptation to high-cholesterol diet, leading to advanced disease development.” Hepatology Communications, vol. 10, no. 12, December 1, 2026 Ovid Technologies (Wolters Kluwer Health), doi: 10.1097/HC9.0000000000001084. <https://doi.org/10.1097/HC9.0000000000001084>.
Cite this page:
- Posted by Elizabeth Taylor